Skip to content

Intraluminal brachytherapy treatment results analysis of unresectable recurrent cholangiocarcinoma

Intraluminal brachytherapy treatment results analysis of unresectable recurrent cholangiocarcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0000738
Enrollment
30
Registered
2013-05-06
Start date
2012-03-08
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : The treatment results among patients treated with conventional treatment alone, chemotherapy, or brachytherapy for locally recurrent cholangiocarcinoma were evaluated.

Sponsors

Chonbuk National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)recurrent cholangiocarcinoma patient who received surgery 2)cholangiocarcinoma patient with cT1N0M0 histocally and imagically diagnosis conformed 3)adenocarcinoma 4)inoperable 5)complete brachytherapy 6)patients received conventional treatment or chemotherapy 7)complete follow up 8)ECOG = 2

Exclusion criteria

Exclusion criteria: 1) patients who underwent radiation therapy in the treatment area with a history in the past 2) patients were diagnosed with secondary cancer of other organs 3) patients who did not complete radiation therapy

Design outcomes

Primary

MeasureTime frame
median survival period

Secondary

MeasureTime frame
complication rates of biliary re-interventions ;median maintained patency period of the stent ;average numbers of repeat percutaneous interventional procedures

Countries

Korea, Republic of

Contacts

Public ContactLee Young

Chonbuk National University Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026